Philippe Funfrock
-
OthersAll you need to know about the main emerging variants of SARS-CoV-2
Philippe Funfrock
Several emerging variants of SARS-CoV-2 have been raising concerns over the past weeks. Three of these variants are being closely monitored across the globe. These were first reported in the…
-
The role of point-of-care tests in tracking and curbing the COVID-19 pandemic
Coordinated strategies, efficient tracking, and vaccination are key to ensure a safe return to normal during the COVID-19 pandemic. But… Read More
-
How the phage display technology is boosting the production of valuable bispecific antibodies
Bispecific antibodies are valuable therapeutics due to their unique ability to engage different epitopes or antigens and thus modulate the… Read More
-
Is genetic immunization a one-size-fits-all solution to accelerate polyclonal antibody generation?
Polyclonal antibodies are valuable tools for research as secondary reagents or therapy as antivenom drugs. However, their production has largely… Read More
-
What types of antibody neutralization tests are currently used in vaccine and drug development?
Measuring the neutralizing response has become vital for the correct assessment of the efficiency of new vaccines and drugs. But… Read More
-
Can antibody therapeutics serve as effective tools to treat and alleviate aggressive rare diseases?
Although rare diseases are characterized by a generalized low incidence in the global population, collectively, over 7,000 different conditions affect… Read More
-
A cross-reactive antibody unravels the unexpected trigger of an aggressive autoimmune disease
Researchers have recently discovered a new mechanism that explains the development of membranous nephropathy (MN), a rare autoimmune disorder. By… Read More
-
What makes antibody therapeutics uniquely fitted to fight autoimmune disorders?
Autoimmune disorders afflict almost 10% of the global population, with a particular incidence in young and middle-aged women. Despite the… Read More
-
How advanced monoclonal antibody generation methods are improving conventional envenoming treatments
Snakebite envenoming has been on WHO’s priority list of neglected tropical diseases since 2017. Due to the complexity and variability… Read More
-
What are the leading monoclonal antibody treatments for cancer?
Arresting cancer progression has evolved from the use of unspecific chemotherapies with serious adverse effects to the adoption of antibody-based… Read More
